Kim, Jong Gwang <br/><br/>
Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer.  [electronic resource] 

 -  Oncology  2005 
 - 190-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0030-2414 
<br/><br/><label>Standard No.: </label>10.1159/000086773  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Capecitabine<br/>Deoxycytidine--administration & dosage<br/>Disease Progression<br/>Docetaxel<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Stomach Neoplasms--drug therapy<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Treatment Outcome